Wuhan University   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Wuhan China (1893)

Organization Overview

First Clinical Trial
2007
NCT00548223
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

9.Zhongnan Hospital of Wuhan University | Aier Eye Affiliated Hospital of Wuhan University | Center for Regenerative Medicine, Renmin Hospital of Wuhan University | Cong-xin Huang | Hospital of Stomatology, Wuhan University | Hubei Cancer Hospital | Hu bei CH | Hubei General Hospital | Hubei People's Hospital | Hui ting Xu，MD | Institute of Burns, Wuhan Third Hospital, Tongren Hospital Wuhan University | People's Hospital of Wuhan University | President of Zhongnan Hospital of Wuhan University | Puren Hospital Affiliated to Wuhan University of Science and Technology | Renmin Hospital of Wuhan University | Renmin Hospital of Zhongshan Guangdong | renmin hospital,yunyang medical college | The Third People's Hospital of Hubei | The third people's Hospital of Hubei Province | Third people's Hospital of Hubei Province | Wuhan Aisa Heart Hospital | Wuhan Hospital of Traditional Chinese Medicine | Wuhan medical treatment center | Wuhan University | Wuhan Xiehe Hospital | Zhongnan Hospital Affiliated to Wuhan University | Zhongnan Hospital of Wuhan University & Second Clinical Hospital of Wuhan University

Active Ingredients

Drugs in Phase 4 Trials (43)

abatacept (orencia) (1 trial)

amfebutamone (1 trial)

amiodarone (cordarone) (1 trial)

amoxicillin (1 trial)

bifidobacterium animalis (1 trial)

bismuth (1 trial)

carrimycin (1 trial)

cenegermin-bkbj (oxervate) (1 trial)

chloroquine (1 trial)

cinacalcet (sensipar) (1 trial)

cisplatin (platinol) (10 trials)

deng zhan sheng mai (1 trial)

dexamethasone (1 trial)

dexmedetomidine (precedex) (1 trial)

digoxin (lanoxin) (1 trial)

endostatin (endostar) (1 trial)

enoxaparin (lovenox) (1 trial)

esketamine (spravato) (2 trials)

esomeprazole (nexium) (1 trial)

etoposide (vepesid) (1 trial)

fluoxetine (prozac) (1 trial)

fluvoxamine (luvox) (1 trial)

furazolidone (furoxone) (1 trial)

gemcitabine (gemzar) (1 trial)

lithium (lithonate) (1 trial)

lopinavir (Kaletra) (2 trials)

mesna (mesnex) (1 trial)

mirtazapine (remeron) (1 trial)

mycophenolate (myfortic) (1 trial)

naltrexone (revia) (1 trial)

oseltamivir (tamiflu) (1 trial)

pegaspargase (oncaspar) (1 trial)

prednisone (meticorten) (4 trials)

propofol (diprivan) (1 trial)

pyrotinib (1 trial)

reduning (1 trial)

remimazolam (1 trial)

ritonavir (Norvir) (1 trial)

secukinumab (cosentyx) (1 trial)

shensong yangxin (1 trial)

thymalfasin (zadaxin) (1 trial)

urea (1 trial)

xingnaojing (1 trial)

Drugs in Phase 3 Trials (22)

bivalirudin (angiomax) (1 trial)

borneol (1 trial)

camrelizumab (4 trials)

capecitabine (xeloda) (5 trials)

carboplatin (paraplatin) (3 trials)

cyclophosphamide (cytoxan) (4 trials)

docetaxel (taxotere) (9 trials)

doxorubicin (Doxil) (3 trials)

ferric citrate (auryxia) (1 trial)

heparin (liquaemin) (1 trial)

irinotecan (Camptosar) (2 trials)

methylprednisolone (medrol) (1 trial)

nedaplatin (1 trial)

oxaliplatin (eloxatin) (5 trials)

paclitaxel (taxol) (5 trials)

qi-zheng-xiao-tong (1 trial)

rc48-adc (1 trial)

sevelamer (renagel) (1 trial)

tong-luo-qu-tong (1 trial)

tyroserleutide (1 trial)

vincristine (oncovin) (3 trials)

vinorelbine (navelbine) (1 trial)

Drugs in Phase 2 Trials (29)

allogeneic human dental pulp stem cell (1 trial)

almonertinib (2 trials)

apatinib (6 trials)

bevacizumab (avastin) (3 trials)

captopril (capoten) (1 trial)

cetuximab (erbitux) (1 trial)

cm082 (1 trial)

fluorouracil (efudex) (6 trials)

fruquintinib (1 trial)

gimeracil (2 trials)

itraconazole (sporanox) (1 trial)

leucovorin (1 trial)

metformin (glucophage) (1 trial)

methotrexate (1 trial)

nimotuzumab (1 trial)

niraparib (zejula) (2 trials)

oteracil (2 trials)

pamiparib (1 trial)

pemetrexed (alimta) (1 trial)

Raltitrexed (2 trials)

sargramostim (leukine) (1 trial)

sintilimab (2 trials)

sodium chloride (1 trial)

surufatinib (2 trials)

tegafur (2 trials)

tislelizumab (1 trial)

toripalimab (2 trials)

umbilical cord mesenchymal stem cells (6 trials)

vitamin c (2 trials)

Drugs in Phase 1 Trials (6)

anlotinib (2 trials)

bs-006 (1 trial)

et1402l1-cart cells (1 trial)

huanglian-jie-du-tang (1 trial)

thalidomide (Thalomid) (1 trial)

zhuyun (1 trial)

Drugs in Other Trials (14)

atropine (1 trial)

cefotiam (ceradon) (1 trial)

das181 (1 trial)

dehydroepiandrosterone (1 trial)

fentanyl (Innovar) (1 trial)

lactulose (cephulac) (2 trials)

letrozole (femara) (1 trial)

osimertinib (tagrisso) (1 trial)

oxycodone (oxycontin) (1 trial)

polyethylene glycol (2 trials)

recombinant human choriogonadotropin alfa (Ovidrel) (1 trial)

rifaximin (xifaxan) (1 trial)

sodium picosulfate (1 trial)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Aneurysm (Phase 3)

Ascites (Phase 2)

Atrial Fibrillation (Phase 4)

Breast Neoplasms (Phase 3)

Carcinoma (Phase 3)

Carcinoma, Hepatocellular (Phase 3)

Carcinoma, Non-Small-Cell Lung (Phase 2)

Carcinoma, Ovarian Epithelial (Phase 3)

Carcinoma, Squamous Cell (Phase 3)

Cardiac Complexes, Premature (Phase 4)

Cerebral Infarction (Phase 4)

Cerebral Small Vessel Diseases (Phase 4)

Cognitive Dysfunction (Phase 4)

Colorectal Neoplasms (Phase 3)

Communicable Diseases (Phase 4)

Coronavirus Infections (Phase 4)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Major (Phase 4)

Disease (Phase 4)

Esophageal Squamous Cell Carcinoma (Phase 3)

Fallopian Tube Neoplasms (Phase 3)

Fever (Phase 2)

Heart Failure (Phase 4)

Hematologic Diseases (Phase 2)

Hemorrhage (Phase 3)

Hyperparathyroidism (Phase 4)

Hyperparathyroidism, Secondary (Phase 4)

Hyperphosphatemia (Phase 3)

Infections (Phase 4)

Infertility (Phase 4)

Influenza, Human (Phase 4)

Intracranial Aneurysm (Phase 3)

Ischemia (Phase 4)

Kidney Diseases (Phase 3)

Kidney Failure, Chronic (Phase 3)

Liver Neoplasms (Phase 2)

Lung Neoplasms (Phase 2)

Lymphoma (Phase 4)

Lymphoma, B-Cell (Phase 3)

Lymphoma, Follicular (Phase 3)

Lymphoma, Large B-Cell, Diffuse (Phase 3)

Lymphoma, T-Cell (Phase 4)

Macular Degeneration (Phase 2)

Malnutrition (Phase 3)

Multiple Myeloma (Phase 1)

Musculoskeletal Diseases (Phase 3)

Nasopharyngeal Carcinoma (Phase 3)

Neoplasm Metastasis (Phase 4)

Neoplasms (Phase 2)

Neoplasms, Plasma Cell (Phase 1)

Osteoarthritis (Phase 3)

Osteoarthritis, Knee (Phase 3)

Ovarian Neoplasms (Phase 3)

Peritoneal Neoplasms (Phase 3)

Pneumonia (Phase 2)

Pneumonia, Ventilator-Associated (Phase 2)

Pneumonia, Viral (Phase 2)

Premature Birth (Phase 4)

Radiation Injuries (Phase 2)

Rectal Neoplasms (Phase 3)

Renal Insufficiency, Chronic (Phase 3)

Stomach Neoplasms (Phase 2)

Stroke (Phase 4)

Subarachnoid Hemorrhage (Phase 3)

Uterine Cervical Neoplasms (Phase 3)

Ventricular Premature Complexes (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 98
  • # of Trial APIs: 114